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Introduction
Exopolysaccharides (EPSs) are defined as; high 
molecular weight, biodegradable polymers which bio-
synthesized by a wide range of organisms (Vijayabaskar 
et al., 2011; Sanlibaba and Çakmak, 2016). The EPS are 
often found in the surroundings of the outer structures 
of prokaryotic as well as eukaryotic microbial cells. They 
are either closely associated with the cell in the form 
of discrete capsules or else are excreted as slime unat-
tached to the cellular surface. They exist in a wide vari-
ety of unique and complex chemical structures and are 
believed to provide self-protection against antimicro-
bial substances growing nearby (Nanda and Raghavan, 
2014). Exopolysaccharides have major roles in different 
processes viz., formation of biofilm (Ohno et al., 2000; 
Vimala and Lalithakumari, 2003), protection of bacterial 
cell from desiccation, for maintaining primary cellular 
functions and antibacterial activity against predators, 
gelling ability, pollutant degradation kinetics and cement 
based construction industry (Bhaskar and Bhosle, 2005; 
Rawal et al., 2016). There are two major types of EPSs 
according to the constituents; homo- and hetero-EPSs. 
Recently, microbial polysaccharides have been attended 
due to their unique properties and the possibility of 
quick mass production. Today, EPSs find wide range of 
applications in food, pharmaceutical, other industries 
(Patil et al., 2009; Nwodo et al., 2012). Also, they have 
proved various physiological activities in human beings 
as anti-tumor, anti-viral and anti-inflammation agents, 
as well as being inducers for interferon, platelet aggre-
gation inhibition, colony stimulating factor synthesis, 
coagulants and lubricants (de Godoi et al., 2014; Li et al., 
2016; Venkateswarulu et al., 2016). A number of micro-
bial strains have the potentiality to produce polysaccha-
rides with widely varying compositions. On the other 
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A b s t r a c t
Exopolysaccharides (EPSs) are high molecular weight polymers consisting of different sugar residues they are preferable for replacing 
synthetic polymers as they are degradable and nontoxic. Many microorganisms possess the ability to synthesize and excrete exopolysac-
charides with novel chemical compositions, properties and structures to have potential applications in different fields. The present study 
attempt to optimize the production of EPS by marine Bacillus subtilis SH1 in addition to characterization and investigation of different 
valuable applications. Effect of medium type, incubation period and pH were studied using the one factor at a time experiments. It was 
shown that the highest productivity (24 gl–1) of exopolysaccharides was recorded by using yeast malt glucose medium with pH 9 at the 
fourth day of incubation. Experimental design using Response Surface Methodology (RSM) was applied to optimize various nutrients at 
different concentrations. The finalized optimized medium contained (gl–1) glucose (5), peptone (2.5), yeast extract (4.5) and malt extract 
(4.5) increased the production of EPS to 33.8 gl–1 with1.4 fold increase compared to the basal medium. Chemical characterization of the 
extracted EPS showed that, FTIR spectra exhibited bands at various regions. Moreover, HPLC chromatogram indicated that the EPS was 
a heteropolysaccharide consisting of maltose and rhamnose. The study was extended to evaluate the potentiality of the extracted poly-
saccharides in different medical applications. Results concluded that, EPS exhibited antibacterial activity against Aeromonas hydrophila, 
Pseudomonas aeruginosa and Streptococcus faecalis and the highest antibacterial activity (7.8, 9 and 10.4 AU/ml) was against S. faecalis at 
50, 100 and 200 mg/ml respectively. The EPS exhibited various degree of antitumor effect toward the tested cell lines (MCF-7, HCT-116 and 
HepG2). In addition, EPS exhibited antiviral activity at 500 µg/ml. The antioxidant capacity increased with increasing the concentration 
of the sample. Scanning electron microscopic analysis showed that EPS had compact film-like structure, which could make it a useful in 
the future applications as in preparing plasticized film. 
K e y  w o r d s: Bacillus subtilis SH1, anticancer, antiviral, exopolysaccharides, response surface methodology
Hassan S.W.M. and H.A.H. Ibrahim 4450
side, EPSs production from marine microorganisms 
such as; Zoogloea sp. (Ikeda et al., 1982), Pseudomonas 
sp. (Matsuda and Worawattanamateekul, 1993), Vibrio 
fischeri (Rodrigues and Bhosle, 1991), Cyanothece 
sp. (Philippis et al., 1993), and Alteromonas macleodii 
(Raguenes et al., 1996) were reported and their proper-
ties were studied well. Furthermore, Bacillus sp. pro-
duces complex EPSs and widely studied species were; 
Bacillus licheniformis, producing levan (Ghaly et al., 
2007), Bacillus coagulans, Bacillus polymyxa (Lee et al., 
1997) and Bacillus mucilaginous (Lian et al., 2008). Bacil-
lus subtilis is also one of the major producers of EPS 
among Bacillus sp. In major reports, B. subtilis is mostly 
found to produce a biopolymer poly-γ-Glutamate 
(PGA) (Jane and HsiuFeng, 2007; Robert et al., 2011), 
levan, fructan (De Melo et al., 2010). The optimization 
process of fermentation is very critical and parameters 
affecting could be carried out using a statistical tool; 
Response Surface Methodo logy (RSM). This method 
has many advantages over the conventional method 
which involves numerous experiments by changing one 
variable at a time with keeping other independent vari-
able constant. The RSM is a reliable tool and a fast exper-
imentation technique which deals with individual effects 
of nutrients and their interactive effects (Wu et al., 2008; 
Rabha et al., 2012; Prathima et al., 2014).
The main goal of the present study was the produc-
tion, maximization and characterization of EPSs from 




Microorganism and culture conditions. Marine 
B. subtilis SH1 was kindly provided by Dr. Hassan A.H. 
Ibrahim; Marine Microbiology Dep., NIOF, Alexandria, 
Egypt. It was isolated upon seawater agar medium from 
Suez Gulf and completely identified by phenotypic and 
genotypic means. The nucleotide sequence was deposi-
ted to GenBank sequence database and has EU107759 
accession number. 
Reference bacterial strains. The bacterial indicator 
strains (Aeromonas hydrophila, Pseudomonas aerugi-
nosa, Staphylococcus aureus, Vibrio damsela, Escherichia 
coli, and Streptococcus faecalis) were kindly provided by 
Marine Microbiology Dep, NIOF, Alexandria, Egypt.
Production of EPS. B. subtilis SH1 was inoculated 
in 50 ml aliquot of nutrient broth medium dispensed 
in 250 ml Erlenmeyer flask, the flask was incubated at 
37°C under shake condition (120 rpm) for overnight. 
After overnight incubation, 500 µl was transferred to 
50 ml of a fresh production media in a conical flask. 
Above step was carried out in an aseptic manner, the 
flask was incubated for 4 days at 37°C.
Extraction of EPS from B. subtilis SH1 culture. 
The marine B. subtilis SH1 culture was centrifuged at 
10,000 g for 10 min at 4°C. The supernatant obtained 
was mixed with two volumes of ice cold ethanol and 
kept at 4°C for 24 h. The mixture was then centri-
fuged at 2500 × g for 20 min at 4°C. The obtained pellet 
was suspended in distilled water, which was centri-
fuged at 2500 × g for 30 min at 4°C with two volumes 
of ice cold ethanol. The process was repeated twice and 
the EPS obtained was dried, weighed and lyophilized 
(Savadogo et al., 2004).
One factor at time experiments
Effect of different media on EPS production. To 
study the effect of media on the production of EPS, 
different media (gl–1) including nutrient broth (Abou- 
Dobara et al., 2014); yeast extract 2, peptone 5, NaCl, 5 
(NB) (Abou-Dobara et al., 2014), soft brown sugar 40; 
MgSO4 . 7H2O 0.2; K2HPO4 9; KH2PO4 3; yeast extract 2 
(SEM) (Tallgren et al., 1999); yeast extract 3, malt extract 
3, glucose 10, peptone 5 (YMG) (Abou-Dobara et al., 
2014); Yeast mannitol (YM), yeast extract 0.5, man-
nitol 4 (Mukherjee et al., 2011) were tested. A liquots 
of 1% (OD = 1 at 600 nm) of the active culture of the 
B. subtilis SH1 which was previously proliferated in 
marine nutrient broth, was used as constant inoculum 
size for each medium.
Effect of different incubation period on EPS pro-
duction. The effect of incubation time was investigated 
by varying time periods (1–6) days. Culture with 1% 
was used as constant inoculum size.
Effect of different pH on EPS production. The 
initial pH for higher product yield was determined by 
adjusting pH with 1M HCl and 1M NaOH before sterili-
zation at different pH as 5, 6, 7, 8, and 9. Culture with 1% 
(OD = 1 at 600 nm) was used as constant inoculum size.
Optimization of culture conditions using RSM. 
Response surface methodology was used to determine 
the optimum concentration of the tested variables for 
enhancement of EPSs production. The variables were 
(glucose, peptone, yeast extract and malt extract). The 
four independent variables were evaluated at five dif-
ferent levels (–2, –1, 0, +1 and +2) and 30 experiments, 
containing 6 replications at the center point as shown 
in Table I. The behavior of the system was explained by 
the following second order polynomial equation:
Y = β0 + β1X1 + β2X2 + β3X3 + β4X4 + β12X1X2 +
      + β13X1X3 + β14X1X4 + β23X2X3 + β24X2X4 +
       + β34X3X4 + β11X12 + β22 X22 + β33X32 + β44X42
Where, Y is the predicted response, β0 is the scal-
ing constant, X1-X4 are the coded levels of the fac-
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tors, β1-β4 are the linear coefficients, β12-β34 are the 
interactive coefficients and β11-β44 are the quadratic 
coefficients. ANOVA and regression analyses were also 
carried out used the above software. The quality of the 
polynomial equation was confirmed by the determina-
tion of coefficient R2 and its statistical significance was 
determined by Fisher’s test, F value. 
Morphological characterization of EPS. Morpho-
logy of dried EPSs was determined by scanning elec-
tron microscopy examination (SEM). EPS was coated 
on gold particles and microstructure was visualized 
under scanning electron micrograph at 3000X. Whole 
and surface view of EPSs was taken and structure was 
analyzed (Yada et al., 2011).
Structural analyses. Pellets for infrared analysis 
were prepared by grinding a mixture of 2 mg polysac-
charide with 200 mg dry KBr, followed by pressing 
the mixture into a 16 mm diameter mold. The Fourier 
transform-infrared (FTIR) spectra were recorded on 
a  Bruker Vector 22 instrument with a resolution of 
4 cm–1 in the 4000–400 cm–1 region. Chemical charac-
terization included UV was carried out using UV spec-
troscopy (Heλiosα). 
Composition of EPSs produced by marine B. sub-
tilis SH1 was done using HPLC system. The EPS iso-
lated from culture was dissolved in distilled water 
and EPS (1 ml) was hydrolyzed with 3 M Tri-fluoro-
acetic acid (TFA) for 1–2 h at 250°C using oil bath. 
1 1 –1 –1 1 24.6 22.8 1.8
2 0 0 0 0 17.6 22.8 1.8
3 0 2 0 0 12.8 21 1.8
4 0 0 0 0 20 17.6 2
5 1 1 1 –1  9.6 21 2.6
6 –1 –1 1 1 33.8  5.8 1.6
7 0 0 0 –2 21.6 25 3.2
8 0 0 0 2 21.2 18 2.4
9 0 0 0 0 24  1.8 1.4
10 1 1 –1 1 31.8 21 2
11 –1 –1 –1 –1 14.4 36.8 1.4
12 –1 1 1 1 29.8 18 2
13 1 –1 1 –1  6.2 36 0.6
14 0 0 2 0 17.8  5.8 1.6
15 –2 0 0 0 33 17.8 1.6
16 0 0 0 0 12 28.6 2.4
17 –1 1 –1 1 23 21 1.2
18 1 1 –1 –1 20.8 20.6 2
19 0 0 0 0 22 26.8 2.2
20 0 0 0 0 20 21 2.4
21 2 0 0 0 24.8 21 2.4
22 0 –2 0 0 24.8 25 1.8
23 –1 1 –1 –1 25.6 21.6 1.4
24 –1 –1 1 –1 15.6 23 1.8
25 1 –1 1 1 16 11.2 1.6
26 –1 –1 –1 1 10.4 10.4 0.4
27 0 0 –2 0 27.4 23.6 1.6
28 –1 1 1 –1 27.4 26.2 2.2
29 1 –1 –1 –1 26.6 26.8 1.8
30 1 1 1 1 24.4 18 1.8
Table I
Central composite design and the EPSs production by B. subtilis SH1 obtained
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Hydrolyzed EPS was neutralized using 5 N NaOH and 
volume was made to 50 ml with MilliQ water. HPLC 
of hydrolyzed EPSs was done by using aminopropile 
column (HI-Plex, Agilent, 4.6 × 250 mm), acetonitrile 
and water was used as mobile phase in ratio of 75:25. 
The separation was carried out at 24°C with flow rate 
of 1 ml/min and sample volume of 20 µl. Monosaccha-
rides such as glucose, arabinose, raffinose, rhamnose, 
maltose, etc. were used as standard. The column was 
calibrated with different molecular mass standard and 
a standard curve was then established (Yada et al., 2011).
Antimicrobial activity of EPS against indicator 
strains. Fifty milliliter of nutrient agar medium inocu-
lated with indicator pathogenic bacteria (1% v/v) were 
poured into all plates. After solidifying, wells were 
punched out using 0.5 cm cork borer, and each of their 
bottoms was then sealed with two drops of sterile water 
agar. One hundred microliters of different concentra-
tions (10, 25, 50, 100 and 200 mg/ml) of filtrated EPS 
were transferred into each well after sterilizing by ultra-
filtration using 0.22 µm sterilized filters. All plates were 
incubated at appropriate temperature for 24–48 h. After 
incubation period, the radius of clear zone around each 
well (Y) and the radius of the well (X) were linearly 
measured in mm, where dividing Y2 over X2 determines 
an absolute unit (AU) for the clear zone. The absolute 
unit of each EPS, which indicates a positive result in the 
antimicrobial action, was calculated according to the 
following equation: AU = Y2/X2 (El-Masry et al., 2002).
Antitumor activity. Human Breast cancer (MCF-7), 
Human colon carcinoma HCT-116 and Hepatocellu-
lar carcinoma (HepG2) cells were obtained from the 
American Type Culture Collection (ATCC, Rockville, 
MD). The cells were grown on RPMI-1640 medium 
supplemented with 10% v/v inactive fetal calf serum 
and 50 µg/ml Gentamycin. The cells were maintained 
at 37°C in a humidified atmosphere with 5% CO2 and 
were subcultured two to three times a week.
The antitumor activity was evaluated on tumor cells. 
The cells were grown as monolayers in growth medium 
supplemented with 10% inactive fetal calf serum and 
50 µg/ml Gentamycin. The monolayers of 10000 cells 
adhered at the bottom of the wells in a 96-well micro-
liter plate incubated for 24 h at 37°C in a humidified 
incubator with 5% CO2. The monolayers were then 
washed with sterile phosphate buffered saline (0.01 M, 
pH 7.2) and simultaneously the cells were treated with 
100 µl from different dilutions of tested sample in fresh 
maintenance medium and incubated at 37°C. A control 
of untreated cells was made in the absence of tested sam-
ple. Six wells were used for each concentration of the test 
sample. Every 24 h the observation under the inverted 
microscope was made. The number of the surviving cells 
was determined by staining the cells with crystal violet 
(Gangadevi and Muthumary, 2007) followed by cell lys-
ing using 33% glacial acetic acid and read the absorb-
ance at 590 nm using ELISA reader (SunRise, TECAN, 
Inc, USA) after well mixing. The absorbance values from 
untreated cells were considered a 100% proliferation.
The number of viable cells was determined using 
ELISA reader as previously mentioned before and the 
percentage of viability was calculated as (ODt/ODc) 
× 100% where ODt is the mean optical density of wells 
treated with the tested sample and ODc is the mean 
optical density of untreated cells. The 50% inhibitory 
concentration (IC50), the concentration required to 
cause toxic effects in 50% of intact cells, was estimated 
from graphic plots.
Antiviral assay
Mammalian cell line. Vero cells (derived from the 
kidney of normal African green monkeys) were obtained 
from agle’s medium supplemented with 10% heat-inacti-
vated fetal bovine serum (FBS), 1% L-glutamine, HEPES 
buffer and Gentamycin (50 µg/ml). All cells were main-
tained at 37°C in a humidified atmosphere with 5% CO2 
and were subcultured two times a week.
Evaluation of the antiviral activity using cyto-
pathic inhibition assay. The screening of antiviral 
assay using cytopathic effect inhibition was carried 
out at the Regional Center for Mycology and Biotech-
nology (RCMB) at Al-Azhar University. This assay was 
selected to show specific inhibition of a biologic func-
tion (Hu and Hsiung, 1989). Monolayers of 1000 vero 
cells adhered at the bottom of the wells in a 96-well 
microliter plate incubated at 24 h at 37°C in a humidi-
fied incubator with 5% CO2. The plates were washed 
with fresh DMEM and challenged with 104 herpes sim-
plex type I virus (HSV-1) doses and simultaneously the 
cultures were treated with two-fold serial dilutions of 
tested compound in fresh maintenance medium and 
incubated at 37°C for 3 days. An infection treatments 
as well as untreated vero cells control was made in the 
absence of tested compound. Six wells were used for 
each concentration of the tested compound. Every 24 h 
the observation under the inverted microscope was 
made until the virus in the control wells showed com-
plete viral- induce cytopathic effects. Antiviral activity 
was determined by the inhibition of cytopathic effect 
compared to control (Vijayan et al., 2004).
Three independent experiments were assessed each 
containing four replicates per treatment. Acyclovir, 
which is clinically used for the treatment of hepatic 
viral disease, was used as a positive control under this 
assay system (Dargan, 1998).
After the incubation period, the media was aspi-
rated, and the cells were stained with a 0.1% crystal 
violet solution for 4 h. The stain was removed and the 
plates rinsed using tap water until all excess stain was 
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removed. The plates were allowed to dry for 24 h and 
then glacial acetic acid (30%) was then added to all 
wells and mixed thoroughly, and then the absorbance of 
the plates were measured after gently shaken on Micro-
plate reader (TECAN, Inc) at 620 nm. Viral Inhibition 
rate was calculated as follows:
[(ODtv-ODcd/ODcv)] × 100%, where ODtv, ODcv and 
ODcd indicate the absorbance of the test compounds 
with virus infected cells, the absorbance of the virus con-
trol and the absorbance of the cell control, respectively.
Data and statistical analysis. From these data, the 
dose that inhibited viral infection by 50% (EC50) was 
estimated with respect to virus control from the graphic 
plots using STATA modeling software. EC50, the effec-
tive concentration needed to restrain 50% virus infec-
tion compared to untreated infected cells, was deter-
mined directly from the curve obtained by plotting the 
inhibition of the virus yield against the concentration 
of the samples. To determine if each compound has 
sufficient antiviral activity that exceeds its level of toxi-
city, a selectively index (SI) was calculated. The selec-
tivity index (SI) was measured from the ratio of the 
concentration at which 50% cytotoxicity was observed 
(CC50/EC50) (Zandi et al., 2007). This index, also 
referred to as a therapeutic index, was used to deter-
mine if a  compound warrants further study. Com-
pounds that had an SI of 2 were considered active, 10 
or greater was considered very active.
Antioxidant activity using DPPH stable free radi-
cal scavenging assay. The DPPH (2,2-diphenyl-1-pic-
ryl-hydrazyl-hydrate) stable free radical scavenging 
assay was performed as previously described by Hu and 
Kitts, 2000 with modifications. Sample was dissolved in 
a methanol at different concentrations ranging from 1 to 
128 μg/ml and then of the sample (2 ml) was incubated 
with 0.5 ml (0.2 mM) DPPH in 100% methanol. Sample 
absorbance at 519 nm was recorded after 30 min of incu-
bation at room temperature. Inhibition of the DPPH 
stable free radical was calculated as follows:
Inhibition % = (AbControl –AbSample)/(AbControl – AbBlank) × 100
Where:
Ab control = absorbance of 0.1 mM DPPH alone in 
  methanol;
Ab sample = absorbance of 0.1 mM DPPH + sample 
  in methanol; and 
Ab blank = absorbance of methanol solvent control 
  in absence of DPPH or sample.
Results and Discussion
B. subtilis is one of the major producers of exopoly-
saccharides (EPSs) among Bacillus sp. Therefore, the cur- 
rent study was suggested to evaluate the production and 
characterization of EPSs from marine B. subtilis SH1, 
as well as, to detect some medical applications of EPSs.
Optimization of fermentation conditions
for EPS production by marine B. subtilis SH1
Effect of different media on EPS production. Dif-
ferent media including NB, SEM, YMG and YM were 
evaluated for the production of EPS by B. subtilis. As 
shown in Fig. 1, YMG medium was the most suitable 
for higher production of EPS with yield of 18 gl–1 fol-
lowed by NB (11.2 gl–1) and YM (8.8 gl–1), while the low-
est production (8.4 gl–1) was recorded up on using SEM 
medium. Similar results were recorded by Abou-Dobara 
et al. (2014), who stated that among seven tested media, 
YMG medium gave the highest production of EPS by 
B. subtilis. They also reported that glucose, malt and 
mannitol support good biomass production. 
Fig. 1. Effect of different media on the production of the EPSs
by marine B. subtilis SH1.
Effect of incubation time on the production of EPS 
by B. subtilis SH1. Incubation time is an essential factor 
determining the enhancement of EPS synthesis in the 
culture. Observation of time course of EPS production 
in association with growth of B. subtilis SH1 at different 
time interval (1–6 days) (Fig. 2) indicated that the pro-
duction of EPS increased gradually from 17.2 gl–1 at the 
first day with biomass of 20 gl–1 to 19.8 gl–1 at the fourth 
day which represented the highest productivity of EPS 
and also the highest biomass production (44 gl–1), while 
the production decreased after that till the last day to 
reach 18 gl–1. This can be explained by the fact that EPS 
is highly synthesized during late exponential growth 
phase and decrease in incubation time may lower the 
production. Higher incubation time might affect the 
yield due to the production of certain enzymes, saccha-
rases, along with EPS, might act upon polysaccharides, 
thus deteriorating the product formation. The result 
of the present work is consistent with similar studies 
carried out earlier which reported the production of 
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EPS by B. subtilis at late phase of growth (72 h) (Lee 
et al., 1997; Vijayabaskar et al., 2011).
Effect of pH on EPS production by B. subtilis SH1. 
The pH is a significant factor influencing the physiology 
of a microorganism by affecting nutrient solubility and 
uptake, enzyme activity, cell membrane morphology, 
by product formation and oxidative-reductive reactions 
(Bajaj et al., 2009). Production of EPS by B. subtilis SH1 
was estimated at different pH (5–9). As shown in Fig. 3, 
the production of EPS increased from 19 gl–1 at pH 5 to 
19.8 gl–1 at pH 7 and the highest productivity of EPS was 
recorded at pH 9 which realized 24 gl–1 which means 
that the production was favorable at the alkaline level. 
These results coincide with those reported by Ko et al. 
(2000), who reported that the highest production of 
EPS by Bacillus sp. was produced at pH 8 and reduced 
in lower pH values. Relatively low concentration of EPS 
produced by B. subtilis was obtained in other studies at 
pH 7 and reduced at lower pH values (Abdul Razack 
et al., 2013). Also, other studies reported that the maxi-
mum production of EPS by B. subtilis was obtained 
at pH 7 and decreased gradually at pH 8 to10 (Abu-
Dobara et al., 2014).
Optimization of EPS production by B. subtilis 
SH1 using Response Surface Methodology (RSM). 
Response Surface Methodology (RSM) was used to 
investigate the influence of different components on 
the yields of biomass and extracellular EPS by B. sub-
tilis SH1. Central composite design with 4 factors at 
five levels was used for fitting data on a second-order 
polynomial model (Table II). The mathematical method 
describing the relationships between the process 
responses (the yield of EPS) and the medium contents 
was developed. Different trials and the response were 
illustrated in Table I.
Glucose (X1) 2.5 5 10 15 20
Peptone (X2) 1.25 2.5 5  7.5 10
Yeast extract (X3) 0.75 1.5 3  4.5 6
Malt extract (X4) 0.75 1.5 3  4.5 6
Table II




–2 –1 0 1 2
Fig. 3. Effect of different pH on the EPSs production
by marine B. subtilis SH1.
Fig. 2. Effect of incubation period on growth and EPSs
production by marine B. subtilis SH1.
Results in Table I showed that the EPS yield varied 
between 6.2–33.8 gl–1. The maximum productivity of 
EPS was achieved at conditions of low concentrations 
of glucose and peptone (5 g and 2.5 g) respectively but 
with high concentrations of yeast extract and malt 
extract (4.5 gl–1). In agreement with the present study, 
Looijesteijn et al. (2000) studied the influence of differ-
ent substrate limitations on EPS production by closely 
related organism namely Lactococccus lactis subsp. cre-
moris. They observed that reduction in glucose resulted 
in slightly higher production of EPS.
Kimmel et al. (1998) reported that higher glucose 
concentration (Carbon source) provides the higher 
yield of EPS for L. lactis sp. Abou-Dobara et al. (2014) 
reported that the highest production of EPS was 
recorded by using yeast extract with a concentration 
of 0.22%. Conversely, reports suggested that nitrogen 
limitation and higher amounts of carbon in the medium 
could yield a  maximum amount of EPS. A  study 
showed that EPS production from Rhizobium meliloti 
was higher when the nitrogen source was in minimal 
quantity. Similarly, pullulan was generated by Aureoba-
sidium pullulans when it was grown in a medium with 
lesser amounts of nitrogen source. On the other hand, 
EPS production was observed under nitrogen-limited 
conditions (Mengistu et al., 1994; Marshall et al., 1995). 
It was observed that the growth culture conditions that 
realized the highest EPS production do not realize the 
highest growth. It was stated that biosynthesis of bio-
mass and EPS biosynthesis follow roughly the same 
metabolic pathways. This results in the same meta-
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bolic control for EPS production and for growth. At 
higher growth rates, more intermediates per time unit 
are needed for the biosynthesis of cell surface polysac-
charides, and the intermediates are apparently used in 
favor of the synthesis of these polysaccharides; this may 
explain the reduction of the EPS yields at higher growth 
rates (Prathima et al., 2014). 
It can be concluded that the present study achieved 
good yield of EPS (33.8 gl–1) using the marine B. subti-
lis SH1 under the optimized conditions which is more 
yield in shorter time than other previous studies such 
as Shukla et al. (2015), who reported that the highest 
production of EPS was 12 gl–1at 144 h. Also, Berekaa 
(2014) stated that the highest yield of EPS by B. licheni-
formis strain-QS5 was 22.5 gl–1at 96 h under the opti-
mized conditions. Thus the marine B. subtilis SH1 is 
promising candidate for EPS production as it is cheap 
and ecofriendly marine source.
Based on the results of the experimental designs, 
a  second order polynomial equation was developed, 
describing the correlation between the variables used 
for study. The EPS yield could be represented as:
Y = 8.40 + 0.553 X1 + 3.738 X2 + 4.510 X3 – 4.191 X4 +
    + 0.081 X21 – 0.341 × 22 – 0.0001 X23–0.261 × 24 –
    – 0.065 X1 X2 – 0.868 X1X3 + 0.118 X1 × 4 – 
    – 0.003 X2X3 + 0.450X2X4 + 1.039 X3X4.
Where, Y is the response i.e. EPS; X1, X2, X3 and X4 
are the uncoded values of the test variables peptone, 
glucose, yeast extract and malt extract. Regression 
equation for the levels of EPS production (Y) as func-
tions of; glucose concentration (X1), peptone concen-
tration (X2), yeast extract (X3), and malt extract (X4) 
suggested that all the four factors influenced the EPS 
production by such organism.
ANOVA and regression analysis done for the expe-
rimental designs are tabulated (Table  III). There was 
a significant difference (p < 0.05) and the second order 
model showed fit with R2 = 0.8.
The results showed that the EPS yield varied 
between 6.2–33.8 gl–1. The maximum productivity of 
EPS was achieved at concentrations (gl–1): glucose, 5; 
peptone, 2.5; yeast extract, 4.5 and malt extract, 4.5. The 
production decreased under other conditions, irrespec-
tive of higher or lower than these levels.
These figures showed that the highest yield of EPS 
was recorded upon decreasing the concentrations of 
glucose and peptone (Fig. 4a) or decreasing the con-
centration of glucose and increasing the concentration 
of yeast extract (Fig. 4b). The same will be realized 
at low glucose concentration and high concentration 
of malt extract (Fig. 4c). Our finding is in accordance 
with Prathima et al. (2014), who reported the produc-
tion of EPS by L. lactis NCDC 191 in a whey based 
medium under glucose limitation using Response Sur-
face Methodology.
Results in Fig. 4d showed that interaction between 
low concentration of peptone and high concentration of 
yeast extract cause increase in the EPS yield, which also 
can be achieved in case of low concentration of pep-
tone and high concentration of malt extract (Fig. 4e). 
On the other hand, increasing concentrations of both 
yeast extract and malt extract achieved the highest yield 
of EPS (Fig. 4f).
Morphological characterization of EPS. Textural 
and rheological properties of EPS are contributed 
by its structure beside its quantity and composition 
(Yada et al., 2011). The EPS obtained from B. sub-
tilis SH1 was observed by SEM (Fig. 5). As it is seen 
from the microstructure of EPS surface view, the pro-
duced EPS is highly compact in structure. This indi-
cates the potential of EPS as viscosifying, as a thickener 
or as stabilizing agent for novel food products (Yada 
et al., 2011).
Structural analyses. The FTIR spectra of the EPS 
(Fig. 6) exhibited bands at various levels. A dominant 
absorption that is often attributed to O-H stretching 
vibration at 3361.74 of O-H in carboxylic acid which 
is accompanied with the bands at 2923.88 cm–1 corre-
sponds to H stretching in carboxylic group. Exopoly-
mers produced by marine bacteria generally contain 
20–50% of the polysaccharide as uronic acid (Kennedy 
and Sutherland, 1987). 
The band at 1740.04 cm–1 approves the stretch-
ing vibration of C = O carbonyl group of an alde-
hyde or ketone. Quite a spectral peak was obtained at 
1628.99 cm–1 indicated amide NH2 bending vibration or 
C = O, C = N stretching vibration of RCONH2. The peak 
at 1370.45 cm–1 identifies the vibration stretching of alkyl 
hyd rogen (CH2-CH3) in aliphatic alkyl group (R-CH2-
CH3). The sharp band was observed at 1222.62 cm–1 
strongly suggesting the stretching vibration of O-H 
group in a phenol. The peak at 1055.33 cm–1 is assigned 
F-value  1.67
P > F  0.167
R2  0.8
Lack of fit 10
Pure error  5
Table III
Statistical analysis of RSM.
Terms EPS
Three dimensional response surface plots represent 
regression equations and illustrate interaction between 
the response and experimental levels of each variable 
was illustrated as shown in Fig. 4a–4f.
Hassan S.W.M. and H.A.H. Ibrahim 4456
to stretching vibration of (C-O, alcohol, ester, ether and 
phenol) groups. It was reported that the EPS extracted 
from marine bacteria showed absorption indicated alk-
enes, ketones, isocyanate and isothiocyanate groups, 
alcohols, ethers, esters carboxylic acids and phenols 
groups (Orsod et al., 2012).
UV spectrum analysis of EPSs (Fig. 7) indicated 
that there was a significant amount of absorption in 
Fig. 4. Response surface plots of interaction between process variables in the EPSs production by B. subtilis SH1.
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the UV area and revealed that the maximum absorp-
tion was at 190 nm. Trabelsi et al. (2009) stated that, 
the 190 ~ 230 nm wavelength area often results from 
n-σ* and/or π-π* transitions, which are found in many 
functional groups such as carboxyl, carbonyl, and ester.
The HPLC chromatogram of EPS in Fig. 8 showed 
the appearance of 2 major peaks, the first peak was at 
retention time 3.08 min with area 5.83% and the second 
peak was at retention time 9.65 min with area 91.23%. 
Based on the chromatogram, it was indicated that 
the EPS is a heteroploysaccharide contains maltose 
and rhamnose. 
Different medical applications of the EPS pro-
duced by B. subtilis SH1. There are four types of acti-
vities detected and estimated for EPSs to be used as 
medical applications; antibacterial, antitumor, antiviral, 
and antioxidant activities.
Antibacterial activity. Different concentrations of 
the extracted EPS (10–200 mg/ml) were screened for 
antibacterial activity against different types of Gram-
positive bacteria (S. aureus, S. faecalis) and Gram-
negative bacteria (E. coli, A. hydrophila, P. aeruginosa, 
V. damsela). Data in Table IV showed that EPS had dif-
ferent range of antibacterial activity against the tested 
bacteria. The highest antibacterial activity (7.8, 9 and 
10.4 AU/ml) was recorded against S. faecalis at 50, 
100 and 200 mg/ml respectively while no inhibitory 
activity was detected against all the tested bacteria at 
lower concentrations (10 and 25 mg/ml). Antibacterial 
Fig. 5. Electron micrograph showing the surface of B. subtilis SH1 EPSs at 3000 X.
Fig. 7. UV analysis of the EPSs produced by B. subtilis SH1.
A. hydrophila ND ND 3.6 5.4 5.4
P. aeroginosa  ND ND 2.8 4.0 4.6
S. aureus ND ND ND ND ND
V. damsela ND ND ND ND ND
E. coli ND ND ND ND ND
S. faecalis ND ND 7.8 9.0 10.4
Table IV






Fig. 6. FTIR spectra of the EPSs produced by B. subtilis SH1.
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activity of EPS was proven in previous studies where 
Anju et al. (2010) isolated EPS from a marine bacterium 
with antibacterial activity against some fish pathogens. 
Also, Shankar et al. (2010) isolated the EPS from four 
biofilm bacteria and the isolated EPS exhibited anti-
microbial activity against different pathogens. In addi-
tion, Orsod et al. (2012) reported that the extracted EPS 
from the marine bacteria which associated with Asian 
sea bass has potential antimicrobial activities against 
different pathogens.
Antitumor activity. The inhibitory effect of different 
concentrations (1.56, 3.13, 6.25, 12.5, 25 and 50 µg/ml) 
of EPS was tested on three different cell lines included 
MCF-7, HCT-116 and HepG2. Results showed that the 
produced EPS exhibited various degree of antitumor 
effect toward the tested cell lines and increasing concen-
trations of EPS resulted in increased rates of tumor inhi-
bition. Results in Fig. 9A showed that, the cell viability of 
HCT-116 was 34.53–9 5.64% which exhibited inhibition 
% of 65.47–4.36% with IC50 = 35.8 µg which is consistent 
with the finding of You et al. (2011), where the obtained 
polysaccharide revealed a marked inhibition of prolif-
eration of HCT 116. Regarding the antitumor effect of 
EPS against MCF-7, results in Fig. 9B showed that the 
Fig. 8. Sugar analysis of EPS produced by B. subtilis SH1 using HPLC.
Fig. 9. Antitumor activity of the EPSs produced B. subtilis SH1
toward A) HCT-116, B) MCF-7 and C) HepG2 cell lines.
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cell viability was 28.12 to 97.84% with inhibition range 
(71.88–2.16%) and exhibited IC50 = 19.4 µg
Fig. 9C shows that the viability % of the HepG2 
cells ranged from 24.63 to 98.56% upon using EPS with 
different concentrations (0.39–50 µg) which means 
that it recorded inhibition range of (1.44–75.37%) 
and exhibited the highest antitumor effect compared 
to MCF-7 and HCT-116 cell lines with IC50 = 22.3 µg. 
The present work agree with that reported by You 
et al. (2011), who studied antitumor activity of differ-
ent types of EPS toward 7 cell lines and reported that 
EPS exhibited the highest antitumor activity toward 
HepG2 (49.93–61.82%). The same result was reported 
by Dahech et al. (2012). It has been reported that the 
difference in antitumor effects of polysaccharides 
depends on their molecular weight, chemical compo-
sition, structure of the polymeric backbone, and degree 
of branching (You et al., 2011).
Antiviral activity. Antiviral activity of EPS pro-
duced by B. subtilis SH1 was proven in different stud-
ies (Ahmed et al., 2010). Polysaccharides are thought to 
inhibit the very early step of viral replication, i.e., virus 
attachment to the cell surface (de Godoi, 2014). In the 
present study, EPS exhibited weak antiviral activity at 
500 µg/ml against HSV-1, suggesting that this polysac-
charide blocked a step in virus replication subsequent 
to virus attachment and entry. This result is in good 
agreement with the finding that increased internaliza-
tion of heparin occurs during HSV-1 entry into cells 
to suggest that viral particles and the polysaccharide 
are co-internalized in endosomes. The polymer may 
inhibit a step in virus replication occurring between 
virus release and the synthesis of late proteins.
Antioxidant activity. The antioxidant capacity of 
EPS was determined by DPPH (2, 2-Diphenyl-2-pic-
ryl-hydrazyl) and revealed that, the sample has a sig-
nificant antioxidant activity compared with ascorbic 
acid as control (Fig. 10). The different concentrations 
of the EPS sample (128, 64, 32, 16, 8, 4, 2, and 1 µg/ml) 
showed different percentages of inhibition (89.89, 
88.86, 87.95, 81.03, 69.35, 38.49, 23.68, and 14.92%), 
respectively. These results revealed that, the antioxi-
dant capacity was increased with increasing the con-
centration of the sample. These results agree with that 
recorded by Abdel-Fattah et al. (2012), who stated that 
the antioxidant activity of levan and their derivatives 
(SL1 and SL2) produced by B. subtilis exhibited a strong 
free radical scavenging activity with DPPH. You et al. 
(2011) also reported the antioxidant activity of different 
types of polysaccharides.
Conclusions
The present study is spotlight on the importance of 
EPS from B. subtilis SH1 and the data confirmed the 
following points:
1. The YMG medium was the most suitable for higher 
production of B. subtilis SH1 EPSs.
2. The production of EPS increased gradually from 
the first day to the fourth day recording the highest 
productivity and the highest productivity of EPS was 
also favorable at the alkaline level.
3. The maximum productivity of EPS was achieved 
using RSM design at conditions of low concentra-
tions of glucose and peptone but with high concen-
trations of yeast extract and malt extract.
4. The structural characterization was done by FTIR 
spectroscopy which exhibited bands at various levels. 
HPLC revealed the presence of maltose and rham-
nose as major component in EPS.
5. EPS produced by B. subtilis SH1 showed valuable 
activities for medical purposes such as antibacterial, 
antitumor, antiviral, and antioxidant. 
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